The DOI matches its Crossref record.
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis
Open accessAbstract
Several risk factors are associated with increased mortality in patients with chronic graft-versus-host disease (cGVHD), but there is considerable variability in the reported factors. Therefore, we evaluated patient, transplantation, and cGVHD characteristics to develop a risk score in 5343 patients with cGVHD. Ten variables were identified as being significant in multivariate analysis of overall survival and nonrelapse mortality (NRM): age, prior acute GVHD, time from transplantation to cGVHD, donor type, disease status at transplantation, GVHD prophylaxis, gender mismatch, serum bilirubin, Karnofsky score, and platelet count. These 10 variables were used to build a cGVHD risk score, and 6 risk groups (RGs) were identified. The 5-year NRM was 5% (1%-9%) in RG1, 20% (19%-23%) in RG2, 33% (29%-37%) in RG3, 43% (40%-46%) in RG4, 63% (53%-74%) in RG5, and 72% (59%-85%) in RG6. The 5-year overall survival was highest at 91% (95% confidence interval [CI]:85%-97%) in RG1, followed by 67% (65%-69%) in RG2, 51% (46%-55%) in RG3, 40% (37%-43%) in RG4, 21% (12%-30%) in RG5, and 4% (0%-9%) in RG6 (all P < .01). This analysis demonstrates the usefulness of data from a large registry to develop risk-score categories for major transplantation outcomes. Validation of this cGVHD risk score is needed in a different population to ensure its broad applicability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506002 · Cited by 573
Cooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., van den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.09.023 · Cited by 472
Self-citationTFOS DEWS II iatrogenic report
Gomes, J. A. P., Azar, D. T., Baudouin, C., Efron, N., Hirayama, M., Horwath-Winter, J., Kim, T., Mehta, J. S., Messmer, E. M., Pepose, J. S., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.004 · Cited by 462
Arai, S., Arora, M., Wang, T., Spellman, S. R., He, W., Couriel, D. R., Urbano-Ispizua, A., Cutler, C. S., Bacigalupo, A. A., Battiwalla, M., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.10.021 · Cited by 440
Self-citationChronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations
Baumrin, E., Loren, A. W., Falk, S. J., Mays, J. W., & Cowen, E. W. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.12.024 · Cited by 59
Retracted
Metadata
- Authors
- Arora, M., Klein, J. P., Weisdorf, D. J., Hassebroek, A., Flowers, M. E. D., Cutler, C. S., Urbano-Ispizua, A., Antin, J. H., Bolwell, B. J., Boyiadzis, M., Cahn, J.-Y., Cairo, M. S., Isola, L., Jacobsohn, D. A., Jagasia, M., Klumpp, T. R., Lee, S. J., Petersdorf, E. W., Santarone, S., Gale, R. P., Schouten, H. C., Spellman, S., Wingard, J. R., Horowitz, M. M., & Pavletic, S. Z.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-06-16
- Volume
- 117
- Issue
- 24
- Pages
- 6714-6720
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2080200044
- Cited by
- 158
- References
- 0
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. https://app.cochat.ai/papers/10.1182/blood-2010-12-323824
- The paper
- Arora, M., Klein, J. P., Weisdorf, D. J., Hassebroek, A., Flowers, M. E. D., Cutler, C. S., Urbano-Ispizua, A., Antin, J. H., Bolwell, B. J., Boyiadzis, M., Cahn, J.-Y., Cairo, M. S., Isola, L., Jacobsohn, D. A., Jagasia, M., Klumpp, T. R., Lee, S. J., Petersdorf, E. W., Santarone, S., . . . Pavletic, S. Z. (2011). Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood. https://doi.org/10.1182/blood-2010-12-323824
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.